Industry groups have identified upfront costs as a barrier to streamlining U.S. drugmaking. The nonprofit API Innovation Center has a proposed answer for how to tilt finances in favor of investments ...
GlobalData on MSN
AbbVie announces $380m investment in North Chicago API facilities
Construction is scheduled to commence in spring 2026, with both facilities anticipated to be fully operational by 2029.
BioDuro and Cenra launch joint venture to expand resilient global API manufacturing capacity: Irvine Californa Thursday, March 5, 2026, 14:00 Hrs [IST] BioDuro, a globally trusted ...
Based on vibe code, Atoms eliminates the need to manually set up project scaffolding and configure environments.
With Renishaw and Apex Additive Technologies, Addiguru is working to combine its multi-sensor monitoring platform, integrating optical, near-infrared (NIR), and long-wave infrared (LWIR) sensing, with ...
From its 17-year development cycle through to its commercial launch, production has always been in Yeztugo’s DNA. | From its ...
Nvidia’s GTC 2026 unveiled AI factories, token-based economics, and agentic systems—signaling a new era where energy converts ...
Investment marks continued progress against AbbVie's $100 billion commitment to U.S. research and development (R&D) and capital investments, including manufacturing, over the next decade Two new ...
Feb 23 (Reuters) - AbbVie (ABBV.N), opens new tab on Monday said it would invest $380 million to build two new active pharmaceutical ingredient manufacturing facilities at its Illinois campus, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results